Abstract
Open-source statistical software development is increasingly the preferred solution for leveraging new statistical methods in the pharmaceutical industry. However, with a long history of relying on licensed analysis software, there are philosophical and organizational barriers to overcome. In particular, the sustainability, reliability, usability, and feasibility of maintaining open-source statistical software long-term must be ensured. Here, we describe the open-source revolution that is emerging in the pharmaceutical industry and how it facilitates greater scaling of innovative analytical methods in statistics. We discuss challenges to open-source software adoption and propose mitigation strategies. Furthermore, we illustrate the potential for open-source software development with examples of successful projects, which highlight the roles of cross-company collaboration, career paths, education, and community building.
| Original language | English |
|---|---|
| Article number | 104613 |
| Journal | Drug Discovery Today |
| ISSN | 1359-6446 |
| DOIs | |
| Publication status | Accepted/In press - 2026 |
Keywords
- Software
- Open source
- Statistics
- Clinical trials
- Pharmaceutical industry
- Academia
Fingerprint
Dive into the research topics of 'The statistical software revolution in pharmaceutical development: challenges and opportunities in open source'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver